Oppenheimer & Co’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-10,900
| Closed | -$231K | – | 1472 |
|
2020
Q4 | $231K | Sell |
10,900
-1,900
| -15% | -$40.3K | ﹤0.01% | 1189 |
|
2020
Q3 | $190K | Sell |
12,800
-2,000
| -14% | -$29.7K | ﹤0.01% | 1167 |
|
2020
Q2 | $218K | Sell |
14,800
-8,000
| -35% | -$118K | 0.01% | 1084 |
|
2020
Q1 | $268K | Hold |
22,800
| – | – | 0.01% | 937 |
|
2019
Q4 | $536K | Hold |
22,800
| – | – | 0.01% | 806 |
|
2019
Q3 | $422K | Sell |
22,800
-1,100
| -5% | -$20.4K | 0.01% | 855 |
|
2019
Q2 | $444K | Sell |
23,900
-8,000
| -25% | -$149K | 0.01% | 861 |
|
2019
Q1 | $780K | Sell |
31,900
-15,526
| -33% | -$380K | 0.02% | 657 |
|
2018
Q4 | $1.23M | Sell |
47,426
-9
| -0% | -$233 | 0.04% | 470 |
|
2018
Q3 | $1.5M | Buy |
47,435
+9,520
| +25% | +$301K | 0.04% | 475 |
|
2018
Q2 | $1.47M | Sell |
37,915
-5,984
| -14% | -$232K | 0.04% | 465 |
|
2018
Q1 | $1.21M | Buy |
+43,899
| New | +$1.21M | 0.03% | 543 |
|